Budd Chiari Syndrome New Poster.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Budd Chiari Syndrome New Poster.Pdf A Rare Case of Budd Chari Syndrome Theepha Thayalakulasingam, M.D, Rehan Mohammed, M.D, Fred A Lopez, M.D, Arthur Zieske, M.D; David Smith, M.D & Lee Engel, M.D. Louisiana State University Health Sciences Center, New Orleans, LA; Department of Medicine Introduction Discussion Con’t. Budd Chiari syndrome is a rare disorder resulting from hepatic Independent variables predicting a worse prognosis include the presence of venous outflow tract obstruction anywhere from the small hepatic veins encephalopathy, ascites, an International Normalized ratio of > 2.3, older age at to the suprahepatic inferior vena cava. The obstruction can be due to diagnosis, higher bilirubin concentration, more severe liver failure, and presence of various causes, but all of which results in either reduction or refractory ascites. Overall survival was 90% 6 months, 82% at 1 year, 82% at 2 years obstruction of hepatic venous outflow. BCS can be further classified as and 80 % at 5 yrs. The main causes of death for patients with BCS are liver failure, primary BCS, where the obstruction is due to venous disease, such as multiorgan failure, and gastrointestinal bleeding thrombosis or phlebitis or secondary BCS where the compressions or invasion by a lesion originating outside the veins. We are presenting a patient with a primary Budd Chiari Syndrome. Conclusions Budd Chiari syndrome is a rare disorder resulting from hepatic venous outflow Case Presentation tract obstruction anywhere from the small hepatic veins to the suprahepatic inferior A 21 year old woman with tobacco abuse, history of two vena cava. Underlying cause of BCS includes myeloprolifereative disorder, miscarriages presented with flu like illness six week prior followed by two malignancy, infections and benign lesion of the liver, oral contraceptives, pregnancy, week history of abdominal pain and abdominal swelling. Patient during post-partum state and hypercoagulable states. Clinical presentation of BCS can vary the two week period complained of early satiety followed by right upper from absence of symptoms to fulminant hepatic failure. The two most commonly quadrant abdominal pain. The pain was described as dull, non radiating Portal venous phase, axial post contrast image of the Axial postcontrast imaging of the liver after a 5 minute delay associated symptoms of BCS are ascites and abdominal pain. Diagnosis of BCS can and constant 5-8/10 in intensity. The pain was aggravated by movement abdomen shows central hepatic hypertrophy causing mass reveals heterogeneously decreased enhancement (arrows) be established noninvasively using Doppler ultrasonography, Computed Tomography effect on the slit-like IVC (arrow). There is also fatty peripherally and homogenous, increased enhancement and alleviated somewhat by pain medications. The patient was initially infiltration of the liver, ascites, and splenomegaly. centrally. (CT) scan or Magnetic Resonance (MR) imaging. The gold standard is venography. evaluated at another hospital and was found to have ascites. Work-up for Liver biopsy can help diagnose BCS in acute or subacute cases and it can also help her ascites including two paracentesis, and imaging studies failed to decide upon treatment options. The treatment for BCS includes medical, radiological reveal a cause for her ascites thus the patient was transferred to our Discussion and surgical treatments. The treatment is individualized to the particular patient. tertiary facility. Budd Chiari Syndrome (BCS) refers to the pathological resulting from obstruction On physical exam, patient had pale conjunctiva, no icterus or or reduction in normal flow of blood out of the liver. It is a rare condition with incidence lymphadenopathy. Abdominal exam revealed distended abdomen with of 1 in 2.5 million persons per year. Underlying cause of BCS includes normoactive bowel sounds, positive fluid wave and shifting dullness, myeloprolifereative disorder, malignancy, infections and benign lesion of the liver, oral increased liver span and no guarding or rigidity or rebound tenderness. contraceptives, pregnancy, post-partum state and hypercoagulable states. Patient also had bilateral pedal edema without any cyanosis, clubbing. The obstruction of hepatic outflow tracts seen in BCS leads to increase in Genitourinary and pelvic exams were unremarkable. sinusoidal pressure and portal hypertension. The venous stasis leads to hepatic On laboratory analysis, patient was leucopenia with WBC of 3.3 x congestion which decreases hepatic perfusion. This can cause ischemic injury to the 103/UL, anemia with Hemoglobin of 11.2 and hematocrit of 34 with an MCV hepatocytes leading to hepatic necrosis, which eventually leads to hepatic fibrosis and of 80 and RDW of 18%. Patient also had total bilirubin of 2.1 mg/dL and PT cirrhosis. A patient can present at any stage of this continuum, thus clinical Liver Biopsy: sinusoidal congestion and hemorrhage, extensive fibrosis and ductular proliferation with no of 20.8 sec, INR of 1.7, and PTT of 38.9 sec. Evaluating for the cause of presentation of BCS varies depending on the acuteness of presentation and degree of clear cholestasis suggestive of obstruction of hepatic veins/venules as seen in Budd Chiari Syndrome. ascites numerous other labs were draw: negative acute viral hepatitis, obstruction. These patient can present with acute, even fulminant hepatic failure, negative HIV testing, Negative EBV titers, CMV IgM and IgG, Negative subacute or chronic hepatic failure. BCS present mainly in the third and fourth decade pregnancy test, ANA, SS-A, Anti-smooth muscle antibody, Anti- and more commonly in women than men. Clinical presentation of BCS can vary from mitochondrial Ab, SPEP/UPEP, Negative Gonorrhea and Chlamydia absence of symptoms to fulminant hepatic failure. Up to 20% of the patient may not screening. A CT scan of abdomen and pelvis was done, and it revealed have any symptoms, while very low < 1.5% of all acute liver failure is accounted for by hepatomegaly, ascites, abnormal appearance of intra-hepatic veins, and BCS. The two most commonly associated symptoms of BCS are ascites and abdominal intra-hepatic portion of IVC. A liver biopsy and hepatic venogram was pain. Other classical signs and symptoms include hepatomegay, fever, abdominal pain, done and it showed a clot in the right hepatic vein with spider web lower extremity edema, gastrointestinal bleeding, and hepatic encephalopathy. collaterals and edematous mass effect on the hepatic veins. Patient was Diagnosis of BCS can be established noninvasively using Doppler ultrasonography, Computed Tomography (CT) scan or Magnetic Resonance (MR) Reference stared on anticoagulation with IV heparin therapy. Hypercoagulable work- 1. Marco Cura, MD, Ziv Haskal MD, Jorge Lopera, MD. Diagnostic and Interventional Radiology for Budd Chiari up revealed low protein C of 37 and borderline low anti-thrombin 3 level imaging. The most prominent feature noted on noninvasive imaging is hepatomegaly Syndrome. RadioGraphics.rsnajnls.org. May-June 2009:669-681. of 63 and a heterozygote mutation of Factor V Leiden. Other markers and caudate lobe hypertrophy. Although, Doppler US, CT, MRI are commonly used to 2. DeLeve et al. Vascular Disorders of the Liver. Hepatology. May 2009;49:1729-1761. diagnose BCS, the gold standard is venography. Liver biopsy can help diagnose BCS 3. Marudanayagam, Ravi et al. Aetiolgy and outcome of acute liver failure. International hepato-Pancreato- such as Protein S, Homocysteine level, lupus anticoagulant, Biliary Association. 2009, 11, 429-434. anticardiolipin, and prothrombin gene G20210A mutation, Factor V Leiden in acute or subacute cases and it can also help decide upon treatment options. The 4. Sarwa Darwish Murad et al. Etiolgoy, Management, and Outcome of the Budd Chiari Syndrome. Annals of were all within normal limit. Work up for Paroxysmal nocturnal treatment for BCS includes medical, radiological and surgical treatments. Medical Internal Medicine. 4 August 2009:151(3):168-175. treatments include anticoagulation to prevent recurrent thrombosis and extension of 5. Dominique-Charles Valla. Primary Budd Chiari Syndrome. Journal of Hepatology 50 (2009) 195-203. hemoglobinuria was also negative. Patient’s pathology result showed 6. Andrew L. Singer et al. Successful Liver Transplantation for Budd-Chiari Syndrome in a Patient with sinusoidal congestion and hemorrhage, extensive fibrosis and ductular existing thrombosis. Local thrombolysis can also be used for acute and subacute BCS Paroxysmal Nocturnal Hemoglobinuria Treated with the Anti-Complement Antibody Eculizumab. Liver proliferation with no clear cholestasis. Finding were suggestive of of less than four weeks duration. Ascites can be treated with low sodium diet, and Transplantation 15:540-543, 2009. diuretics. Treating underlying causes whenever possible is also essential to relieve 7. Selcuk Sozer et al. The presence of JAK2V61F mutation in the liver endothelial cells of patients with Budd obstruction of hepatic veins/venules and seen in Budd Chiari Syndrome. Chiari Syndrome. May 21, 2009. 113 (21): 5246-5249. Patient’s abdominal pain and distention improved greatly during this symptoms. Radiological and surgical interventions include angioplasty, Transjugular 8. RP Hasija, A Nagral, S Marar, and Bavdekar. Transjugular Intrahepatic Portosystemic Shunt (TIPSS) for Budd hospital course. She was started on long term anticoagulation with intrahepatic portosystemic shunting (TIPS), Stenting, Shunting procedures and liver Chiari Syndrome. Indian Pediatrics. June 17, 2010; 47: 527-528. Coumadin and was sent home with Hematology and Hepatology and transplant. The treatment is individualized to the particular patient. 9. Dutta TK, Venugopal V. Venous thromboembolism: The intricacies. Journal of Postgraduate Medicine. January 2009:55 (1):55-64. Oncology follow-up. .
Recommended publications
  • General Signs and Symptoms of Abdominal Diseases
    General signs and symptoms of abdominal diseases Dr. Förhécz Zsolt Semmelweis University 3rd Department of Internal Medicine Faculty of Medicine, 3rd Year 2018/2019 1st Semester • For descriptive purposes, the abdomen is divided by imaginary lines crossing at the umbilicus, forming the right upper, right lower, left upper, and left lower quadrants. • Another system divides the abdomen into nine sections. Terms for three of them are commonly used: epigastric, umbilical, and hypogastric, or suprapubic Common or Concerning Symptoms • Indigestion or anorexia • Nausea, vomiting, or hematemesis • Abdominal pain • Dysphagia and/or odynophagia • Change in bowel function • Constipation or diarrhea • Jaundice “How is your appetite?” • Anorexia, nausea, vomiting in many gastrointestinal disorders; and – also in pregnancy, – diabetic ketoacidosis, – adrenal insufficiency, – hypercalcemia, – uremia, – liver disease, – emotional states, – adverse drug reactions – Induced but without nausea in anorexia/ bulimia. • Anorexia is a loss or lack of appetite. • Some patients may not actually vomit but raise esophageal or gastric contents in the absence of nausea or retching, called regurgitation. – in esophageal narrowing from stricture or cancer; also with incompetent gastroesophageal sphincter • Ask about any vomitus or regurgitated material and inspect it yourself if possible!!!! – What color is it? – What does the vomitus smell like? – How much has there been? – Ask specifically if it contains any blood and try to determine how much? • Fecal odor – in small bowel obstruction – or gastrocolic fistula • Gastric juice is clear or mucoid. Small amounts of yellowish or greenish bile are common and have no special significance. • Brownish or blackish vomitus with a “coffee- grounds” appearance suggests blood altered by gastric acid.
    [Show full text]
  • Non-Hepatic Hyperammonaemia: an Important, Potentially Reversible Cause of Encephalopathy
    Postgrad Med J 2001;77:717–722 717 Postgrad Med J: first published as 10.1136/pmj.77.913.717 on 1 November 2001. Downloaded from CASE REPORTS Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy N D Hawkes, G A O Thomas, A Jurewicz, O M Williams, C E M Hillier, I N F McQueen, G Shortland Abstract Case reports The clinical syndrome of encephalopathy CASE 1 is most often encountered in the context of A 20 year old man was admitted to a local hos- decompensated liver disease and the diag- pital with two days of inappropriate behaviour, nosis is usually clear cut. Non-hepatic clumsiness, drowsiness, memory loss, slurred causes of encephalopathy are rarer and speech, and abdominal discomfort. Since the tend to present to a wide range of medical age of 2 years he had suVered recurrent rectal specialties with variable and episodic bleeding and investigation had revealed haem- symptoms. Delay can result in the devel- orrhoids. Bleeding from his rectum had contin- opment of potentially life threatening ued over the years but had been worse recently. complications, such as seizures and coma. On examination he was confused. His Early recognition is vital. A history of Glasgow coma scale score (GCS) was 15/15. similar episodes or clinical risk factors Neurological and general examination was nor- and early assessment of blood ammonia mal, with no stigmata of chronic liver disease. levels help establish the diagnosis. In Investigations showed a leucocytosis (leuco- × 9 addition to adequate supportive care, cyte count 22 10 /l) and serum bilirubin level investigation of the underlying cause of of 32 µmol/l.
    [Show full text]
  • PERFORATED PEPTIC ULCER. Patient Usually Experiences
    Postgrad Med J: first published as 10.1136/pgmj.12.134.470 on 1 December 1936. Downloaded from 470 POST-GRADUATE MEDICAL JOURNAL December, 1936 PERFORATED PEPTIC ULCER. By RONALD W. RAVEN, F.R.C.S. (Assistant Surgeon to T'he French Hospital, Assistant Surgeon to The Gordon Hospital for Rectal Diseases and Swrgical Registrar to The Royal Cancer Hospital.) INTRODUCTION. Peptic ulceration is a crippling disease judged from the stand-point of morbidity, and is also dangerous to life on account of serious complications, such as haemorrhage or perforation which may supervene during the course of the disease. These complications may occur in any patient and there are no criteria which will indicate whether or not an ulcer will bleed or perforate. When the treatment of peptic ulceration is under review it must be remembered that from 20 to 30 per cent. of these ulcers perforate. In a large series of cases I found that the incidence of perforation was 27 per cent. It is thus essential that patients suffering with peptic ulcer should be kept under continuous careful observation. Unfortunately, however, a small percentage of patients give no previous history of the peptic ulcer syndrome and perforation of the ulcer is the first indication of its presence. Recently, when considering the role of surgery in the treatment of chronic peptic ulcer, Joll stated that there has been a rise in the incidence of perforation as a complication of peptic ulcer since medical treatment has become systematized in the treatment of this disease. It must also be remembered that medical treat- Protected by copyright.
    [Show full text]
  • Atypical Abdominal Pain in a Patient with Liver Cirrhosis
    IMAGE IN HEPATOLOGY January-February, Vol. 17 No. 1, 2018: 162-164 The Official Journal of the Mexican Association of Hepatology, the Latin-American Association for Study of the Liver and the Canadian Association for the Study of the Liver Atypical Abdominal Pain in a Patient With Liver Cirrhosis Liz Toapanta-Yanchapaxi,* Eid-Lidt Guering,** Ignacio García-Juárez* * Gastroenterology Department. National Institute of Medical Science and Nutrition “Salvador Zubirán”. Mexico City. Mexico. ** Interventional Cardiology. National Institute of Cardiology “Ignacio Chávez”. Mexico City. Mexico. ABSTRACTABSTABSTABSTRACT The causes of abdominal pain in patients with liver cirrhosis and ascites are well-known but occasionally, atypical causes arise. We report the case of a patient with a ruptured, confined abdominal aortic aneurysm. KeyK words.o d .K .Key Liver cirrhosis. Abdominal aortic aneurysm. INTRODUCTION CASE REPORT Abdominal pain in cirrhotic patients is a challenge. A 47-year-old male with the established diagnosis of Clinical presentation can be non-specific and the need for alcohol-related liver cirrhosis, presented to the emer- early surgical exploration may be difficult to assess. Coag- gency department for abdominal pain. He was classified ulopathy, thrombocytopenia, varices, and ascites need to as Child Pugh (CP) C stage (10 points) and had a model be taken into account, since they can increase the surgical for end stage liver disease (MELD) - sodium (Na) of 21 risk. Possible differential diagnoses include: Complicated points. The pain was referred to the left iliac fossa, with umbilical, inguinal or postoperative incisional hernias, an intensity of 10/10. It was associated to low back pain acute cholecystitis, spontaneous bacterial peritonitis, pep- with radicular stigmata (primarily S1).
    [Show full text]
  • High Risk Percutaneous Endoscopic Gastrostomy Tubes: Issues to Consider
    NUTRITIONINFLAMMATORY ISSUES BOWEL IN GASTROENTEROLOGY, DISEASE: A PRACTICAL SERIES APPROACH, #105 SERIES #73 Carol Rees Parrish, M.S., R.D., Series Editor High Risk Percutaneous Endoscopic Gastrostomy Tubes: Issues to Consider Iris Vance Neeral Shah Percutaneous endoscopy gastrostomy (PEG) tubes are a valuable tool for providing long- term enteral nutrition or gastric decompression; certain circumstances that complicate PEG placement warrant novel approaches and merit review and discussion. Ascites and portal hypertension with varices have been associated with poorer outcomes. Bleeding is one of the most common serious complications affecting approximately 2.5% of all procedures. This article will review what evidence exists in these high risk scenarios and attempt to provide more clarity when considering these challenging clinical circumstances. INTRODUCTION ince the first Percutaneous Endoscopic has been found by multiple authors to portend a poor Gastrostomy tube was placed in 1979 (1), they prognosis in PEG placement (3,4, 5,6,7,8). This review Shave become an invaluable tool for providing will endeavor to provide more clarity when considering long-term enteral nutrition (EN) and are commonly used these challenging clinical circumstances. in patients with dysphagia following stroke, disabling motor neuron diseases such as multiple sclerosis and Ascites & Gastric Varices amyotrophic lateral sclerosis, and in those with head The presence of ascites is frequently viewed as a and neck cancer.They are also used for patients with relative, if not absolute, contraindication to PEG prolonged mechanical intubation, as well as gastric placement. Ascites adds technical difficulties and the decompression in those with severe gastroparesis, risk for potential complications (see Table 1).
    [Show full text]
  • Pathophysiology, Diagnosis, and Management of Pediatric Ascites
    INVITED REVIEW Pathophysiology, Diagnosis, and Management of Pediatric Ascites ÃMatthew J. Giefer, ÃKaren F. Murray, and yRichard B. Colletti ABSTRACT pressure of mesenteric capillaries is normally about 20 mmHg. The pediatric population has a number of unique considerations related to Intestinal lymph drains from regional lymphatics and ultimately the diagnosis and treatment of ascites. This review summarizes the physio- combines with hepatic lymph in the thoracic duct. Unlike the logic mechanisms for cirrhotic and noncirrhotic ascites and provides a sinusoidal endothelium, the mesenteric capillary membrane is comprehensive list of reported etiologies stratified by the patient’s age. relatively impermeable to albumin; the concentration of protein Characteristic findings on physical examination, diagnostic imaging, and in mesenteric lymph is only about one-fifth that of plasma, so there abdominal paracentesis are also reviewed, with particular attention to those is a significant osmotic gradient that promotes the return of inter- aspects that are unique to children. Medical and surgical treatments of stitial fluid into the capillary. In the normal adult, the flow of lymph ascites are discussed. Both prompt diagnosis and appropriate management of in the thoracic duct is about 800 to 1000 mL/day (3,4). ascites are required to avoid associated morbidity and mortality. Ascites from portal hypertension occurs when hydrostatic Key Words: diagnosis, etiology, management, pathophysiology, pediatric and osmotic pressures within hepatic and mesenteric capillaries ascites produce a net transfer of fluid from blood vessels to lymphatic vessels at a rate that exceeds the drainage capacity of the lym- (JPGN 2011;52: 503–513) phatics. It is not known whether ascitic fluid is formed predomi- nantly in the liver or in the mesentery.
    [Show full text]
  • Picquestion of the Week:3/09/09
    McKechnie Field - Spring Training Home of the Pirates PIC QUESTION OF THE WEEK: 3/09/09 Q: Why is rifaximin used in patients with pouchitis? A: Pouchitis is an inflammation of the internal pouch fashioned from small intestinal tissue during ileal pouch anal anastamosis (IPAA). This surgical procedure bypasses the large intestine and may be employed in patients with ulcerative colitis or Crohn’s disease. A temporary ileostomy is placed to allow the pouch to heal without risk of infection. IPAA is considered preferable to an ostomy for patients suffering from inflammatory bowel diseases refractory to medical treatment. The pouch serves as a collection device for waste, but permits the patient to experience regular bowel movements. It is typical for patients with an internal pouch to experience more frequent (average 6 per day) and watery bowel movements. Pouchitis is the most common complication of IPAA and widely regarded as an idiopathic disease; however, colonization by fecal bacteria may be a contributing factor. The condition occurs most commonly in the first six months following reversal of the ileostomy. Although its frequency decreases after six months, nearly 50% of patients with an IPAA will eventually experience pouchitis. Presenting symptoms include diarrhea, increased frequency of bowel movements, bleeding, abdominal pain, and fever. It can result in dehydration and, in severe cases, hospitalization. Treatment of acute pouchitis generally consists of a two-week course of antibiotic therapy with metronidazole or ciprofloxacin. Approximately 10% of patients do not respond to initial treatment and develop chronic (> 4 weeks) pouchitis. A small number of clinical trials support the potential use of rifaximin for the treatment of refractory or recurrent pouchitis.
    [Show full text]
  • Abdominal Examination
    Abdominal Examination Introduction Wash hands, Introduce self, ask Patients name & DOB & what they like to be called, Explain examination and get consent Expose and lie patient flat General Inspection Patient: stable, pain/discomfort, jaundice, pallor, muscle wasting/cachexia Around bed: vomit bowels etc Hands Flapping tremor (hepatic encephalopathy) Nails: clubbing (cirrhosis, IBD, coeliacs), leukonychia (hypoalbuminemia in liver cirrhosis), koilonychia (iron deficiency anaemia) Palms: palmar erythema (hyperdynamic circulation due to ↑oestrogen levels in liver disease/ pregnancy), Dupuytren’s contracture (familial, liver disease), fingertip capillary glucose monitoring marks (diabetes) Head Eyes: sclera for jaundice (liver disease), conjunctival pallor (anaemia e.g. bleeding, malabsorption), periorbital xanthelasma (hyperlipidaemia in cholestasis) Mouth: glossitis/stomatitis (iron/ B12 deficiency anaemia), aphthous ulcers (IBD), breath odor (e.g. faeculent in obstruction; ketotic in ketoacidosis; alcohol) Neck and torso Ask patient to sit forwards: Neck: feel for lymphadenopathy from behind – especially Virchow's node (gastric malignancy) Back inspection: spider naevi (>5 significant), skin lesions (immunosuppression) Ask patient to relax back: Chest inspection: spider naevi (>5 significant), gynaecomastia, loss of axillary hair (all due to ↑oestrogen levels in liver disease/ pregnancy) Abdomen Inspection: distension (Fluid, Flatus, Fat, Foetus, Faeces), incisional hernias (ask patient to cough), scars, striae (pregnancy,
    [Show full text]
  • Diagnosis and Management of Primary Biliary Cholangitis Ticle
    REVIEW ArtICLE 1 see related editorial on page x Diagnosis and Management of Primary Biliary Cholangitis TICLE R Zobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD1, David Bernstein, MD, FAASLD, FACG, AGAF, FACP2, Mitchell L. Shifman, MD3, Paul Kwo, MD4, W. Ray Kim, MD5, Kris V. Kowdley, MD6 and Ira M. Jacobson, MD7 Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune disease with a variable progressive course. PBC can cause debilitating symptoms including fatigue and pruritus and, if left untreated, is associated with a high risk of cirrhosis and related complications, liver failure, and death. Recent changes to the PBC landscape include a REVIEW A name change, updated guidelines for diagnosis and treatment as well as new treatment options that have recently become available. Practicing clinicians face many unanswered questions when managing PBC. To assist these healthcare providers in managing patients with PBC, the American College of Gastroenterology (ACG) Institute for Clinical Research & Education, in collaboration with the Chronic Liver Disease Foundation (CLDF), organized a panel of experts to evaluate and summarize the most current and relevant peer-reviewed literature regarding PBC. This, combined with the extensive experience and clinical expertise of this expert panel, led to the formation of this clinical guidance on the diagnosis and management of PBC. Am J Gastroenterol https://doi.org/10.1038/s41395-018-0390-3 INTRODUCTION addition, diagnosis and treatment guidelines are changing and a Primary biliary cholangitis (PBC) is a chronic, cholestatic, auto- number of guidelines have been updated [4, 5]. immune disease with a progressive course that may extend over Because of important changes in the PBC landscape, and a num- many decades.
    [Show full text]
  • A Rare Case of Ascites
    Clinical Medicine 2019 Vol 19, No 2: s73 CLINICAL A r a r e c a s e o f a s c i t e s Authors: S h u a n n S h w a n a , A d n a n U r R a h m a n a n d E l i z a b e t h S l o w i n s k a A i m s most cases depends on whether it is idiopathic or secondary. The mainstay of treatment is corticosteroids; if there is no response, A 69-year-old gentleman presented with a 5-week history of immunosuppressive therapy can be used. Case-series data exist, abdominal distension. He had a past history of diabetes and which show that high-dose corticosteroids like prednisolone are myocardial infarction, and was an ex-smoker with no significant effective in reducing the chronic inflammatory response caused by history of alcohol intake. Examination demonstrated a distended, retroperitoneal fibrosis; however, there is a high rate of recurrence non-tender abdomen with shifting dullness, no organomegaly and once the steroids are withdrawn. Mycophenolate mofetil in addition no signs of chronic liver disease. to corticosteroids has been shown to reduce duration of steroid use without affecting the efficacy and reduces disease recurrence. ■ M e t h o d s Investigations included an ultrasound scan of the abdomen, an Conflict of interest statement ascitic tap, a computed tomography (CT) of the abdomen/pelvis N o n e d e c l a r e d .
    [Show full text]
  • Ilbpnp55ecxs1d55pt2h4cnta 12-Year-Old Girl with Chronic Vomiting
    A 12-year-old girl with chronic vomiting and epigastric pain History: A 12-year-old girl has presented with vomiting for 1 month. The frequency is about 2-3 times a day. The vomitus contains digested food without bile stain. The emesis is not related to meals. After vomiting, she can normally eat. Her bowel movement is once daily with normal stools. There is no fever. After 2 days of symptoms, she was treated with antibiotics and antiemesis with a diagnosis of gastroenteritis. However, the symptom persists. Three weeks prior to admission, the vomiting became worsening (7-8 times a day) and occurred a half an hour after meals. Its characteristics remained the same. At this time, she also complained of epigastric pain, weakness, and anorexia. She was admitted to a primary care hospital and treated with intravenous fluid. The symptoms seemed to be improved. However, the vomiting resumed with a history of foul-smell watery diarrhea 2 time a day for 1 weeks before admission to Children's hospital. She lost significant weight during the illness. Past history: She was admitted because of Dengue hemorrhagic fever 2 years ago. Perinatal and immunization history are normal. There is no genetic and atopic diseases in the family. The patient refuses a history of contact tuberculosis. She denies regular uncooked food ingestion. Physical examination: General appearance- Thai girl, obesity, alert Body weight 80 kg, height 158 cm Vital signs: T 37 C, PR 80/min, RR 18/min, BP 110/70 mmHg HEENT: not pale, no jaundice, pharynx and tonsils-not injected, normal TM Heart: regular rhythm, no murmur Lungs: normal breath sound, no adventitious sound Abdomen: soft, mild distension, mild tenderness at epigastrium, no guarding, no rigidity, active bowel sound, no abnormal mass, fluid thrill and shifting dullness can not be evaluated.
    [Show full text]
  • Dysphagia to Liver Failure Vincent Ting Fung Cheung,1 Jey Singanayagam,2 Angus Molyneux,3 Neil Rajoriya1
    Images in… BMJ Case Reports: first published as 10.1136/bcr-2015-212522 on 26 November 2015. Downloaded from Dysphagia to liver failure Vincent Ting Fung Cheung,1 Jey Singanayagam,2 Angus Molyneux,3 Neil Rajoriya1 1Department of DESCRIPTION Gastroenterology, Milton A 54-year-old man presenting with dysphagia, Keynes University Hospital, Milton Keynes, UK weight loss, epigastric pain and cervical lymphaden- 2Department of Radiology, opathy was referred directly to endoscopy. The Milton Keynes University medical history included hypertension and hyper- Hospital, Milton Keynes, UK 3 cholesterolaemia. Blood tests showed normal biliru- Department of bin, aspartate transaminase (AST) 490 iu/L, Histopathology, Milton Keynes γ University Hospital, Milton -glutamyl transferase (GGT) 535 iu/L, alkaline Keynes, UK phosphatase (ALP) 829 iu/L and prothrombin time (PT) 13 s. Correspondence to Gastroscopy showed a lower oesophageal lesion Dr Vincent Ting Fung Cheung, fi [email protected] ( gure 1) with biopsies showing high-grade dyspla- sia. A CT scan showed lower oesophageal wall Accepted 19 September 2015 thickening and multiple lymphadenopathy in the chest/abdomen but no liver metastases (figure 2). The local multidisciplinary team meeting outcome was for repeat oesophageal biopsies and supraclavi- cular lymph node biopsy to exclude a lymphoma. The patient thereafter clinically deteriorated over Figure 2 CT scan showing oesophageal cancer (red a 4-week period, developing jaundice. On admis- arrow) but no obvious liver lesions. sion, he became overtly encephalopathic within 48 h, with a suggestion of acute liver failure. Bloods revealed: bilirubin 238 μmol/L, AST 1034 iu/L, GGT 569 iu/L, ALP 887 iu/L, albumin 20 g/L, PT 27.2 s and lactate 4.7 mmol/L.
    [Show full text]